 | • レポートコード：MRC2103G188 • 出版社/出版日：Transparency Market Research / 2020年12月3日 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：包装 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界のブリスターパック医薬品市場を広く調査・分析し、エグゼクティブサマリー、イントロダクション、市場見解、新型コロナウイルス感染症の影響、市場分析、薬品種類別（錠剤、カプセル）分析、製造工程別分析、最終用途別分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争状況、仮定、調査手法など、以下の構成でまとめております。 ・エグゼクティブサマリー ・イントロダクション ・市場見解 ・新型コロナウイルス感染症の影響 ・市場分析 ・ブリスターパック医薬品の世界市場規模：薬品種類別（錠剤、カプセル） ・ブリスターパック医薬品の世界市場規模：製造工程別 ・ブリスターパック医薬品の世界市場規模：最終用途別 ・ブリスターパック医薬品の世界市場規模：地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ） ・市場構造分析 ・競争状況 ・仮定 ・調査手法 |
Blister Pack Pharmaceutical Products Market – Scope of the Report
Transparency Market Research (TMR) started a new study on the global blister pack pharmaceutical products market, providing forecast for the period of 2020-2030. In the study, growth opportunity for the blister pack pharmaceutical products market is witnessed. The report provides valuable insights, which enable readers to make winning business decisions for future growth of their businesses. The report highlights significant factors that are constantly determining the growth of the blister pack pharmaceutical products market, untapped opportunities for manufacturers, trends and developments, and other insights across various key segments. Macroeconomic factors that are directly or indirectly affecting market growth are also incorporated in the report.
Key Questions Answered in TMR’s Blister Pack Pharmaceutical Products Market Report
What will be market size for blister pack pharmaceutical products by the end of 2030?
What will be the impact of COVID-19 on blister pack pharmaceutical products market?
Which is the most preferred manufacturing process for packaging of blister packed pharmaceutical products in the global market?
Which region will remain most lucrative for market growth?
Which end use segment holds maximum market share of the global blister pack pharmaceutical products market?
Who are major key players in the blister pack pharmaceutical products market?
Key indicators associated with the blister pack pharmaceutical products market have been calculated thoroughly in the report. The study enumerates vital market dynamics such as key drivers, challenges, and trends, along with opportunities in the global blister pack pharmaceutical products market. A comprehensive study on the value chain, which includes component suppliers, manufacturers, distributors, and end users have been incorporated in the global market report. Other key aspects laid down in the market include pricing strategy of leading market players and comparative analysis of blister pack pharmaceutical products. Furthermore, forecast factors and forecast scenarios of the blister pack pharmaceutical products market have been covered in the report to understand future prospects of the market.
A comprehensive evaluation and forecast on the blister pack pharmaceutical products market are provided on the drug type, manufacturing process, end use, and region.
Y-o-Y growth comparison, revenue comparison, and market share comparison of various market segments are provided in the report. The blister pack pharmaceutical products market is analyzed at both regional and country levels.
The report delivers an exhaustive assessment on the structure of the blister pack pharmaceutical products market, in tandem with a dashboard view of all leading company profiles in the report. Every company’s share analysis on market players have also been presented in the report, apart from the footprint matrix of profiled market players. The report depicts the presence of blister pack pharmaceutical products manufacturers by leveraging an intensity map. It also highlights key end users for blister pack pharmaceutical products.
The report includes company overview of key players. Some of the key companies profiled in the blister pack pharmaceutical products market report include Pfizer Inc, GlaxoSmithKline plc, Sanofi, Roche Holding AG, Novartis AG, Allergan, Johnson & Johnson, Merck, Sun Pharmaceutical Industries Ltd, Cadila Healthcare, etc.
Research Methodology
A realistic methodology, along with a holistic approach makes the base for sharp insights, which are provided in the blister pack pharmaceutical products market for the study evaluation period. The TMR report comprises of detailed information on growth prospects, along with riveting insights into the forecast assessment of the market.
Extensive primary and secondary researches have been employed to garner keen insights into the forecast study of the blister pack pharmaceutical products market. The report has further undergone a cross-validation by in-house professionals to make the blister pack pharmaceutical products market report one-of-its-kind with the highest credibility.
レポート目次1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. TMR Analysis and Recommendations
1.4. Opportunity Analysis
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Market Viewpoint
3.1. Global Economic Outlook
3.2. Global Pharmaceutical Market Overview
3.3. Macro-Economic Factors and Co-relation Analysis
3.4. Forecast Factors – Relevance and Impact
3.5. Value Chain Analysis
3.5.1. Exhaustive List of Active Participants
3.5.1.1. Raw Material Suppliers
3.5.1.2. Manufacturers
3.5.1.3. Distributers/End Users
3.5.2. Profitability Margins
4. Impact of COVID-19
4.1.1. Current Statistics and Probable Future Impact
4.1.2. Current Economic Projection – GDP/GVA and Probable Impact
4.1.3. Comparison of SAARs and Market Recovery, for Key Countries
4.1.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries
4.1.5. Impact of COVID-19 on Blister Pack Pharmaceutical Products Market
5. Blister Pack Pharmaceutical Products Market Analysis
5.1. Market Value (US$ Mn) and Analysis & Forecast
5.2. Y-o-Y Growth Projections
5.3. Absolute $ Opportunity Analysis
6. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Drug Type
6.1. Section Summary
6.2. Introduction
6.2.1. Market share and Basis Points (BPS) Analysis By Drug Type
6.2.2. Y-o-Y Growth Projections By Drug Type
6.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
6.3.1. Tablets
6.3.2. Capsules
6.4. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
6.4.1. Tablets
6.4.2. Capsules
6.5. Market Attractiveness Analysis By Drug Type
7. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Manufacturing Process
7.1. Section Summary
7.2. Introduction
7.2.1. Market share and Basis Points (BPS) Analysis By Manufacturing Process
7.2.2. Y-o-Y Growth Projections By Manufacturing Process
7.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
7.3.1. Cold Forming
7.3.2. Thermoforming
7.4. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
7.4.1. Cold Forming
7.4.2. Thermoforming
7.5. Market Attractiveness Analysis By Manufacturing Process
8. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By End Use
8.1. Section Summary
8.2. Introduction
8.2.1. Market share and Basis Points (BPS) Analysis By End Use
8.2.2. Y-o-Y Growth Projections End Use
8.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
8.3.1. Pharmaceuticals
8.3.2. Nutraceuticals and Supplements
8.3.3. Veterinary Drugs
8.4. Market Size (US$ Mn) Forecast 2020-2030, By End Use
8.4.1. Pharmaceuticals
8.4.2. Nutraceuticals and Supplements
8.4.3. Veterinary Drugs
8.5. Market Attractiveness Analysis By End Use
9. Global Blister Pack Pharmaceutical Products Market Analysis and Forecast, By Region
9.1. Section Summary
9.2. Introduction
9.2.1. Market share and Basis Points (BPS) Analysis By Region
9.2.2. Y-o-Y Growth Projections By Region
9.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Region
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa (MEA)
9.4. Market Size (US$ Mn) Forecast 2020-2030 By Region
9.4.1. North America
9.4.2. Latin America
9.4.3. Europe
9.4.4. Asia Pacific
9.4.5. Middle East and Africa (MEA)
9.5. Market Attractiveness Analysis By Region
10. North America Blister Pack Pharmaceutical Products Market Analysis and Forecast
10.1. Section Summary
10.2. Introduction
10.2.1. Market share and Basis Points (BPS) Analysis By Country
10.2.2. Y-o-Y Growth Projections By Country
10.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
10.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
10.4.1. U.S.
10.4.2. Canada
10.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
10.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
10.6.1. Tablets
10.6.2. Capsules
10.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
10.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
10.8.1. Cold Forming
10.8.2. Thermoforming
10.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
10.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
10.10.1. Pharmaceuticals
10.10.2. Nutraceuticals and Supplements
10.10.3. Veterinary Drugs
10.11. Prominent Trends
11. Latin America Blister Pack Pharmaceutical Products Market Analysis and Forecast
11.1. Section Summary
11.2. Introduction
11.2.1. Market share and Basis Points (BPS) Analysis By Country
11.2.2. Y-o-Y Growth Projections By Country
11.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
11.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
11.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
11.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
11.6.1. Tablets
11.6.2. Capsules
11.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
11.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
11.8.1. Cold Forming
11.8.2. Thermoforming
11.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
11.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
11.10.1. Pharmaceuticals
11.10.2. Nutraceuticals and Supplements
11.10.3. Veterinary Drugs
11.11. Prominent Trends
12. Europe Blister Pack Pharmaceutical Products Market Analysis and Forecast
12.1. Section Summary
12.2. Introduction
12.2.1. Market share and Basis Points (BPS) Analysis By Country
12.2.2. Y-o-Y Growth Projections By Country
12.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
12.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
12.4.1. Germany
12.4.2. Spain
12.4.3. Italy
12.4.4. France
12.4.5. U.K.
12.4.6. BENELUX
12.4.7. NORDIC
12.4.8. Russia
12.4.9. Poland
12.4.10. Rest of Europe
12.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
12.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
12.6.1. Tablets
12.6.2. Capsules
12.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
12.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
12.8.1. Cold Forming
12.8.2. Thermoforming
12.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
12.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
12.10.1. Pharmaceuticals
12.10.2. Nutraceuticals and Supplements
12.10.3. Veterinary Drugs
12.11. Prominent Trends
13. Asia Pacific Blister Pack Pharmaceutical Products Market Analysis and Forecast
13.1. Section Summary
13.2. Introduction
13.2.1. Market share and Basis Points (BPS) Analysis By Country
13.2.2. Y-o-Y Growth Projections By Country
13.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
13.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
13.4.1. China
13.4.2. India
13.4.3. Japan
13.4.4. ASEAN
13.4.5. Australia and New Zealand
13.4.6. Rest of APAC
13.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
13.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
13.6.1. Tablets
13.6.2. Capsules
13.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
13.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
13.8.1. Cold Forming
13.8.2. Thermoforming
13.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
13.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
13.10.1. Pharmaceuticals
13.10.2. Nutraceuticals and Supplements
13.10.3. Veterinary Drugs
13.11. Prominent Trends
14. Middle East and Africa Blister Pack Pharmaceutical Products Market Analysis and Forecast
14.1. Section Summary
14.2. Introduction
14.2.1. Market share and Basis Points (BPS) Analysis By Country
14.2.2. Y-o-Y Growth Projections By Country
14.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
14.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
14.4.1. GCC countries
14.4.2. Northern Africa
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of MEA
14.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
14.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
14.6.1. Tablets
14.6.2. Capsules
14.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
14.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
14.8.1. Cold Forming
14.8.2. Thermoforming
14.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
14.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
14.10.1. Pharmaceuticals
14.10.2. Nutraceuticals and Supplements
14.10.3. Veterinary Drugs
14.11. Prominent Trends
15. Market Structure Analysis
15.1. Market Analysis, by Tier of Companies
15.2. Market Concentration
15.3. Market Presence Analysis
16. Competitive Landscape
16.1. Competition Dashboard
16.2. Company Market Share Analysis
16.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)
16.4. Competition Deep Dive
16.4.1.1. Pfizer Inc
16.4.1.1.1. Overview
16.4.1.1.2. Product Portfolio
16.4.1.1.3. Profitability
16.4.1.1.4. Sales Footprint
16.4.1.1.5. Competition Benchmarking
16.4.1.1.6. Strategy
16.4.1.1.6.1. Marketing Strategy
16.4.1.1.6.2. Product Strategy
16.4.1.1.6.3. Channel Strategy
16.4.1.2. GlaxoSmithKline plc
16.4.1.2.1. Overview
16.4.1.2.2. Product Portfolio
16.4.1.2.3. Profitability
16.4.1.2.4. Sales Footprint
16.4.1.2.5. Competition Benchmarking
16.4.1.2.6. Strategy
16.4.1.2.6.1. Marketing Strategy
16.4.1.2.6.2. Product Strategy
16.4.1.2.6.3. Channel Strategy
16.4.1.3. Sanofi
16.4.1.3.1. Overview
16.4.1.3.2. Product Portfolio
16.4.1.3.3. Profitability
16.4.1.3.4. Sales Footprint
16.4.1.3.5. Competition Benchmarking
16.4.1.3.6. Strategy
16.4.1.3.6.1. Marketing Strategy
16.4.1.3.6.2. Product Strategy
16.4.1.3.6.3. Channel Strategy
16.4.1.4. Roche Holding AG
16.4.1.4.1. Overview
16.4.1.4.2. Product Portfolio
16.4.1.4.3. Profitability
16.4.1.4.4. Sales Footprint
16.4.1.4.5. Competition Benchmarking
16.4.1.4.6. Strategy
16.4.1.4.6.1. Marketing Strategy
16.4.1.4.6.2. Product Strategy
16.4.1.4.6.3. Channel Strategy
16.4.1.5. Novartis AG
16.4.1.5.1. Overview
16.4.1.5.2. Product Portfolio
16.4.1.5.3. Profitability
16.4.1.5.4. Sales Footprint
16.4.1.5.5. Competition Benchmarking
16.4.1.5.6. Strategy
16.4.1.5.6.1. Marketing Strategy
16.4.1.5.6.2. Product Strategy
16.4.1.5.6.3. Channel Strategy
16.4.1.6. Allergan
16.4.1.6.1. Overview
16.4.1.6.2. Product Portfolio
16.4.1.6.3. Profitability
16.4.1.6.4. Sales Footprint
16.4.1.6.5. Competition Benchmarking
16.4.1.6.6. Strategy
16.4.1.6.6.1. Marketing Strategy
16.4.1.6.6.2. Product Strategy
16.4.1.6.6.3. Channel Strategy
16.4.1.7. Johnson & Johnson
16.4.1.7.1. Overview
16.4.1.7.2. Product Portfolio
16.4.1.7.3. Profitability
16.4.1.7.4. Sales Footprint
16.4.1.7.5. Competition Benchmarking
16.4.1.7.6. Strategy
16.4.1.7.6.1. Marketing Strategy
16.4.1.7.6.2. Product Strategy
16.4.1.7.6.3. Channel Strategy
16.4.1.8. Merck
16.4.1.8.1. Overview
16.4.1.8.2. Product Portfolio
16.4.1.8.3. Profitability
16.4.1.8.4. Sales Footprint
16.4.1.8.5. Competition Benchmarking
16.4.1.8.6. Strategy
16.4.1.8.6.1. Marketing Strategy
16.4.1.8.6.2. Product Strategy
16.4.1.8.6.3. Channel Strategy
16.4.1.9. Sun Pharmaceutical Industries Ltd
16.4.1.9.1. Overview
16.4.1.9.2. Product Portfolio
16.4.1.9.3. Profitability
16.4.1.9.4. Sales Footprint
16.4.1.9.5. Competition Benchmarking
16.4.1.9.6. Strategy
16.4.1.9.6.1. Marketing Strategy
16.4.1.9.6.2. Product Strategy
16.4.1.9.6.3. Channel Strategy
16.4.1.10. Cadila Healthcare
16.4.1.10.1. Overview
16.4.1.10.2. Product Portfolio
16.4.1.10.3. Profitability
16.4.1.10.4. Sales Footprint
16.4.1.10.5. Competition Benchmarking
16.4.1.10.6. Strategy
16.4.1.10.6.1. Marketing Strategy
16.4.1.10.6.2. Product Strategy
16.4.1.10.6.3. Channel Strategy
17. Assumptions and Acronyms
18. Research Methodology
Table 01: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 02: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 03: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 04: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Region
Table 05: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 06: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 07: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 08: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 09: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 10: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 11: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 12: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 13: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 14: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 15: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 16: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 17: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 18: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 19: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 20: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
Table 21: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
Table 22: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
Table 23: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
Table 24: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country value (US$ Bn) 2015H-2030F, by Drug Type